search
Back to results

Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions (FCET2EC)

Primary Purpose

Aphasia, Stroke

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Intensive integrative aphasia therapy
Waiting list control group
Sponsored by
University Hospital Muenster
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Aphasia focused on measuring Communication, Language, Treatment, Intervention, Therapy, Efficacy, Maintenance, Recovery, Outcome, Rehabilitation, Treatment Intensity, Language Impairment, Intensive Language Therapy, Functional Communication, Functional Improvement, Evidence-Based Intervention, High-Frequency

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • presence of aphasia for at least 6 months after non-hemorrhagic or hemorrhagic cortical or subcortical-cortical stroke
  • native language German
  • participant's comprehension ability needs to be sufficiently high to give informed consent
  • participant's language abilities have to allow the administration of the Aachen Aphasia Test (AAT)

Exclusion Criteria:

  • aphasia due to non-vascular etiology
  • no evidence for aphasia (based on AAT subtests 'Token Test' and 'Written Language'
  • severe untreated medical conditions which prohibit participation in intensive language therapy
  • severe vision or hearing problems (uncorrected)
  • participation in another interventional or language therapy study within four weeks before potential enrollment

Sites / Locations

  • University of Muenster

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Intensive aphasia therapy group

Waiting list control group

Arm Description

Group starts intensive integrative aphasia therapy within 3 workdays (or as soon as possible) after baseline exam

Group starts intensive integrative aphasia therapy after a waiting period of at least three weeks

Outcomes

Primary Outcome Measures

Changes on the Amsterdam Nijmegen Everyday Language Test (ANELT) - A-scale
Mean gain in ANELT understandability scores (ANELT A-scale; using the parallel versions ANELT-I and ANELT-II)

Secondary Outcome Measures

morbidity measure: changes in language-systematic aphasia screening (SAPS)
Changes from pre- to post therapy of scores on: a (yet unpublished) test to assess language performance in 2 language modalities (perception, production) and 3 language levels (phonological, lexical, morphosyntactic). There are 3 different levels of complexity for each combination of modality and language level. Performance is thus assessed in 18 language domains (2x3x3).
morbidity measure: changes in communicative-pragmatic screening (KOPS)
Changes from pre- to post therapy of scores on: an (yet unpublished) test measuring verbal and nonverbal performance in daily life communicative activities of increasing complexity
morbidity measure: changes in Modified Rankin Scale
Changes from pre- to post therapy of scores in: the degree of disability or dependence in daily activities
quality of life measure: changes in German version of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)
Changes from pre- to post therapy of scores on: Health-related quality of life questionnaire adapted for persons with aphasia
quality of life measure: changes in Communicative Effectiveness Index (CETI) and the ANELT partner communication questionnaire
Changes from pre- to post therapy of scores on: ratings of functional communication ability by relatives of persons with aphasia
morbidity measure: changes in nonverbal cognitive functions
Changes from pre- to post therapy of scores on: Nonverbal Learning Test (NVLT) Trail Making Test Verbal Fluency Test
quality of life measure: changes in Visual analog mood scales (VAMS)
Changes from pre- to post therapy of scores on: assessment of mood visual analog scales (adapted for persons with aphasia)
changes in Amsterdam-Nijmegen Everyday Language Test (ANELT) - B-scale
Mean gain in ANELT intelligibility scores (ANELT B-scale; using the parallel versions ANELT-I and ANELT-II)
changes in Amsterdam-Nijmegen Everyday Language Test (ANELT) - syntactic rating
Mean gain in syntactic rating scores (syntax rating criteria based on AAT subtest "spontaneous speech") for the ANELT scenarios (using the parallel versions ANELT-I and ANELT-II)
changes in Amsterdam-Nijmegen Everyday Language Test (ANELT) - nonverbal communication rating
Mean gain in nonverbal rating scores (criteria based on "Scenario Test") for the ANELT scenarios (using the parallel versions ANELT-I and ANELT-II)

Full Information

First Posted
February 6, 2012
Last Updated
September 25, 2017
Sponsor
University Hospital Muenster
Collaborators
Fresenius University of Applied Science, Charite University, Berlin, Germany, Entwicklungsgruppe Klinische Neuropsychologie, Klinikum Bogenhausen, München, Institut für Biometrie und Klinische Epidemiologie, Charité Campus Benjamin Franklin, Berlin, RWTH Aachen University, Bundesverband für die Rehabilitation der Aphasiker e.V., Universitätsklinikum Leipzig, MEDIAN Klinik Grünheide, Brandenburgklinik Berlin-Brandenburg GmbH, St. Mauritius Therapieklinik, Aphasie- und Seniorenzentrum Josef Bergmann Vechta, Behandlungs- und Rehabilitationszentrum für Intensiv-Therapie Lindlar, Wickerklinik Bad Homburg v.d.H., Asklepios Neurological Clinic Falkenstein, Akademische Praxis für Sprachtherapie / Praxis für Rehabilitationswesen Aschaffenburg, Städtisches Klinikum München, Klinikum Bogenhausen, Schoen Clinic Bad Aibling, m&i-Fachklinik Bad Liebenstein, m&i-Fachklinik Enzensberg, m&i-Fachklinik Herzogenaurach, mediclin Klinikum Soltau, Moritz Klinik, Bad Klosterlausnitz, Klinikum Christophsbad, Göppingen, P.A.N.-Zentrum
search

1. Study Identification

Unique Protocol Identification Number
NCT01540383
Brief Title
Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions
Acronym
FCET2EC
Official Title
From Controlled Experimental Trial to Everyday Communication: How Effective is Intensive Aphasia Therapy Under Routine Clinical Conditions?
Study Type
Interventional

2. Study Status

Record Verification Date
September 2017
Overall Recruitment Status
Completed
Study Start Date
April 2012 (undefined)
Primary Completion Date
January 2015 (Actual)
Study Completion Date
January 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital Muenster
Collaborators
Fresenius University of Applied Science, Charite University, Berlin, Germany, Entwicklungsgruppe Klinische Neuropsychologie, Klinikum Bogenhausen, München, Institut für Biometrie und Klinische Epidemiologie, Charité Campus Benjamin Franklin, Berlin, RWTH Aachen University, Bundesverband für die Rehabilitation der Aphasiker e.V., Universitätsklinikum Leipzig, MEDIAN Klinik Grünheide, Brandenburgklinik Berlin-Brandenburg GmbH, St. Mauritius Therapieklinik, Aphasie- und Seniorenzentrum Josef Bergmann Vechta, Behandlungs- und Rehabilitationszentrum für Intensiv-Therapie Lindlar, Wickerklinik Bad Homburg v.d.H., Asklepios Neurological Clinic Falkenstein, Akademische Praxis für Sprachtherapie / Praxis für Rehabilitationswesen Aschaffenburg, Städtisches Klinikum München, Klinikum Bogenhausen, Schoen Clinic Bad Aibling, m&i-Fachklinik Bad Liebenstein, m&i-Fachklinik Enzensberg, m&i-Fachklinik Herzogenaurach, mediclin Klinikum Soltau, Moritz Klinik, Bad Klosterlausnitz, Klinikum Christophsbad, Göppingen, P.A.N.-Zentrum

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to examine whether 3 weeks of intensive language therapy provided in clinical in- and outpatient settings is effective in improving everyday communication in postacute/chronic post-stroke aphasia, as measured by performance on the Amsterdam Nijmegen Everyday Language Test (ANELT).
Detailed Description
Aims of the study: This multicenter randomized placebo-controlled study aims to examine whether integrative intensive (> 10 hours/week for at least 3 weeks) language and communication therapy administered under routine clinical conditions translates into a statistically significant functional improvement of everyday communication in patients with chronic aphasia (i.e., aphasia persisting for 6 or more months after the stroke). A further aim is to examine whether therapy-induced improvements are still maintained over a period of six months. The study's results may lead to more targeted treatment regimens and thus to an enhancement of health-related quality of life in persons with chronic aphasia. The data will further provide evidence-based guidelines of best practice in the rehabilitation of persons with chronic aphasia. Methods: Fourteen in- and outpatient rehabilitation centres across Germany participate in the study. Via a digital randomization procedure, patients are allocated to one of two groups: an experimental group, starting as soon as feasible with treatment lasting 3 to 6 weeks, and a waiting list control group, whose therapy begins after a three-week delay. Both groups receive a combination of language systematic and communicative-pragmatic language therapy. Everyday language ability will be examined with a standardized outcome measure, and compared between groups at several points: immediately before as well as immediately after and 6 months after completion of (3-6 weeks) intensive language therapy. Statistical analyses: The primary analysis compares the changes in functional communication ability (as indicated by changes of pre- to post-therapy functional communication scores on the primary outcome measure, the ANELT) between the experimental and the waiting list control group in an intention-to-treat (ITT) design. To balance for unequal treatment durations across patient ("naturalistic treatment setting"), the critical pre- to post therapy interval is fixed at three weeks, with the option of extension of therapy (provided it is granted by the sickness fund) and re-test after termination of therapy. The long-term stability of potential treatment gains will be re-evaluated 6 months post therapy. Further exploratory analyses will examine therapy-induced changes in secondary outcome measures (see below) in the experimental compared to the waiting list control group. Considering that age, gender, time post stroke onset, aphasia type (fluent, non-fluent), aphasia severity (based on the Aachen Aphasia Test [AAT] profile score), the total hours of therapy provided, type of stroke (cortical strokes with or without subcortical involvement), the amount of therapy-concomitant self-administered language practice (e.g. computer-aided practice), and concurrent physio- and neuropsychological therapies might influence functional outcome, the above factors will be included in a multivariate analysis with variable selection. The amount of outpatient therapy provided after discharge from intensive treatment will be statistically controlled by covariate analyses. Finally, the investigators expect that therapy effects in the waiting list control group will be comparable to those of the experimental group. Thus, after initiation of therapy in the control group after a three-week delay, outcome data will be collected in analogy to the experimental group, and will serve to replicate potential effects of intensive language therapy under routine clinical conditions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Aphasia, Stroke
Keywords
Communication, Language, Treatment, Intervention, Therapy, Efficacy, Maintenance, Recovery, Outcome, Rehabilitation, Treatment Intensity, Language Impairment, Intensive Language Therapy, Functional Communication, Functional Improvement, Evidence-Based Intervention, High-Frequency

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
156 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intensive aphasia therapy group
Arm Type
Experimental
Arm Description
Group starts intensive integrative aphasia therapy within 3 workdays (or as soon as possible) after baseline exam
Arm Title
Waiting list control group
Arm Type
Other
Arm Description
Group starts intensive integrative aphasia therapy after a waiting period of at least three weeks
Intervention Type
Behavioral
Intervention Name(s)
Intensive integrative aphasia therapy
Intervention Description
Intensive language therapy (3 weeks, 5 days/week, >=2 hours/day) provided in regular clinical setting and consisting of a combination of language systematic and communicative-pragmatic treatment
Intervention Type
Behavioral
Intervention Name(s)
Waiting list control group
Intervention Description
Control group starts intensive language therapy after a 3-week waiting period.
Primary Outcome Measure Information:
Title
Changes on the Amsterdam Nijmegen Everyday Language Test (ANELT) - A-scale
Description
Mean gain in ANELT understandability scores (ANELT A-scale; using the parallel versions ANELT-I and ANELT-II)
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Secondary Outcome Measure Information:
Title
morbidity measure: changes in language-systematic aphasia screening (SAPS)
Description
Changes from pre- to post therapy of scores on: a (yet unpublished) test to assess language performance in 2 language modalities (perception, production) and 3 language levels (phonological, lexical, morphosyntactic). There are 3 different levels of complexity for each combination of modality and language level. Performance is thus assessed in 18 language domains (2x3x3).
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Title
morbidity measure: changes in communicative-pragmatic screening (KOPS)
Description
Changes from pre- to post therapy of scores on: an (yet unpublished) test measuring verbal and nonverbal performance in daily life communicative activities of increasing complexity
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Title
morbidity measure: changes in Modified Rankin Scale
Description
Changes from pre- to post therapy of scores in: the degree of disability or dependence in daily activities
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Title
quality of life measure: changes in German version of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)
Description
Changes from pre- to post therapy of scores on: Health-related quality of life questionnaire adapted for persons with aphasia
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Title
quality of life measure: changes in Communicative Effectiveness Index (CETI) and the ANELT partner communication questionnaire
Description
Changes from pre- to post therapy of scores on: ratings of functional communication ability by relatives of persons with aphasia
Time Frame
Baseline is compared to performance 6 months post 3 weeks of intensive language therapy.
Title
morbidity measure: changes in nonverbal cognitive functions
Description
Changes from pre- to post therapy of scores on: Nonverbal Learning Test (NVLT) Trail Making Test Verbal Fluency Test
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Title
quality of life measure: changes in Visual analog mood scales (VAMS)
Description
Changes from pre- to post therapy of scores on: assessment of mood visual analog scales (adapted for persons with aphasia)
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Title
changes in Amsterdam-Nijmegen Everyday Language Test (ANELT) - B-scale
Description
Mean gain in ANELT intelligibility scores (ANELT B-scale; using the parallel versions ANELT-I and ANELT-II)
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Title
changes in Amsterdam-Nijmegen Everyday Language Test (ANELT) - syntactic rating
Description
Mean gain in syntactic rating scores (syntax rating criteria based on AAT subtest "spontaneous speech") for the ANELT scenarios (using the parallel versions ANELT-I and ANELT-II)
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)
Title
changes in Amsterdam-Nijmegen Everyday Language Test (ANELT) - nonverbal communication rating
Description
Mean gain in nonverbal rating scores (criteria based on "Scenario Test") for the ANELT scenarios (using the parallel versions ANELT-I and ANELT-II)
Time Frame
Baseline is compared to performance immediately and 6 months post 3 weeks of intensive language therapy. Patients with at least 5 weeks of therapy, performance will also be assessed after therapy completion (on average 6 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: presence of aphasia for at least 6 months after non-hemorrhagic or hemorrhagic cortical or subcortical-cortical stroke native language German participant's comprehension ability needs to be sufficiently high to give informed consent participant's language abilities have to allow the administration of the Aachen Aphasia Test (AAT) Exclusion Criteria: aphasia due to non-vascular etiology no evidence for aphasia (based on AAT subtests 'Token Test' and 'Written Language' severe untreated medical conditions which prohibit participation in intensive language therapy severe vision or hearing problems (uncorrected) participation in another interventional or language therapy study within four weeks before potential enrollment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Annette Baumgaertner, PhD
Organizational Affiliation
Hochschule Fresenius University of Applied Science
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Caterina Breitenstein, PhD
Organizational Affiliation
Neurology, University of Muenster
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Agnes Floel, MD
Organizational Affiliation
Neurology, Universitätsmedizin Charite, CCM, Berlin
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Wolfram Ziegler, PhD
Organizational Affiliation
Clinical Neuropsychology Research Group (EKN), Klinikum Bogenhausen, München
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Tanja Grewe, PhD
Organizational Affiliation
Hochschule Fresenius University of Applied Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Muenster
City
Muenster
State/Province
North Rhine-Westfalia
ZIP/Postal Code
48149
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
28256356
Citation
Breitenstein C, Grewe T, Floel A, Ziegler W, Springer L, Martus P, Huber W, Willmes K, Ringelstein EB, Haeusler KG, Abel S, Glindemann R, Domahs F, Regenbrecht F, Schlenck KJ, Thomas M, Obrig H, de Langen E, Rocker R, Wigbers F, Ruhmkorf C, Hempen I, List J, Baumgaertner A; FCET2EC study group. Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting. Lancet. 2017 Apr 15;389(10078):1528-1538. doi: 10.1016/S0140-6736(17)30067-3. Epub 2017 Mar 1. Erratum In: Lancet. 2017 Apr 15;389(10078):1518.
Results Reference
derived
PubMed Identifier
24059983
Citation
Baumgaertner A, Grewe T, Ziegler W, Floel A, Springer L, Martus P, Breitenstein C. FCET2EC (From controlled experimental trial to = 2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial. Trials. 2013 Sep 23;14:308. doi: 10.1186/1745-6215-14-308.
Results Reference
derived

Learn more about this trial

Effectiveness of Intensive Aphasia Therapy Under Routine Clinical Conditions

We'll reach out to this number within 24 hrs